About Trice Medical
Trice Medical is a company based in King Of Prussia (United States) founded in 2012. Trice Medical has raised $85.47 million across 12 funding rounds from investors including Bioventus, Smith & Nephew and Safeguard Scientifics. Trice Medical has completed 2 acquisitions, including SegWAY Orthopaedics and Tenex Health. Trice Medical offers products and services including TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
- Headquarter King Of Prussia, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Trice Medical Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$85.47 M (USD)
in 12 rounds
-
Latest Funding Round
$10.5 M (USD), Series D
Aug 04, 2023
-
Investors
Bioventus
& 7 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
SegWAY Orthopaedics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trice Medical
Trice Medical offers a comprehensive portfolio of products and services, including TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
Device for removing soft tissue in tendinopathy treatments.
Tool for bone spur and calcification removal procedures.
Application for treating wounds and foot ulcers effectively.
Systems for carpal tunnel and cubital tunnel releases.
Needlescope for small joint arthroscopy and diagnostics.
People of Trice Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Trice Medical
Trice Medical has successfully raised a total of $85.47M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $10.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series D — $10.5M
-
First Round
First Round
(04 Oct 2012)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series D - Trice Medical | Valuation |
investors |
|
| Aug, 2021 | Amount | Series D - Trice Medical | Valuation | Bioventus |
|
| Mar, 2020 | Amount | Series C - Trice Medical | Valuation |
investors |
|
Investors in Trice Medical
Trice Medical has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Smith & Nephew and Safeguard Scientifics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early and growth stage companies
|
Founded Year | Domain | Location | |
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Trice Medical
Trice Medical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SegWAY Orthopaedics and Tenex Health.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Minimally invasive therapies are provided for diseased tendon removal.
|
2009 | ||||
|
Endoscopic guide systems for orthopedic extremity procedures are developed.
|
2007 |
Financial Statements - Trice Medical
Trice Medical Comparisons
Competitors of Trice Medical
Latest news on Trice Medical
Frequently Asked Questions about Trice Medical
Trice Medical was founded in 2012.
Trice Medical is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Mike Steen is the current CEO of Trice Medical.
Trice Medical is a funded company, having raised a total of $85.47M across 12 funding rounds to date. The company's 1st funding round was a Series C of $2.12M, raised on Oct 04, 2012.
Trice Medical was founded in 2012 and is headquartered in King of Prussia, United States. Needle-based diagnostic and therapeutic technologies for orthopedics are provided by the company. The FDA-approved Mi-eye product is a disposable visualization device that incorporates a camera and light source into a standard 14-gauge needle. Diagnostic arthroscopies are enabled in office settings through this technology.
Trice Medical offers TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
Trice Medical has made 2 acquisitions, including SegWAY Orthopaedics, and Tenex Health.
Trice Medical has 8 investors. Key investors include Bioventus, Smith & Nephew, Safeguard Scientifics, Health Quest Capital, and MERS.